PHC Holdings Corporation Overview
Pro stress-test →PHC Holdings Corporation provides medical devices, healthcare IT solutions, and life science products and services primarily in Japan, with a global presence across diabetes management, diagnostic systems, and advanced healthcare technology. The company's consolidated net sales in FY2024 were JPY 361.6 billion with global distribution in more than 125 countries and regions.
Strategic Profile
Pro stress-test →Expansion in high-margin diabetes and digital pathology products, plus healthcare IT, positions PHC to benefit from digitalization and recurring service revenues. The company operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments, with recent strategic moves including cell and gene therapy platform development and CGM technology partnerships.
Competitive Landscape
Pro stress-test →PHC Holdings is covered by 8 analysts, with 6 submitting revenue or earnings estimates. Key competitors in diabetes management include DexCom and Senseonics (now acquiring Eversense distribution from PHC). In pathology and life sciences, PHC competes with global diagnostic and laboratory equipment providers. The company's integrated portfolio spanning diabetes, diagnostics, and healthcare IT provides differentiation versus single-category competitors.
Industry Context
PHC Holdings Corporation operates in Healthcare Equipment & Digital Health Solutions.
Key facts
Founded: 1969 · Headquarters: Tokyo, Japan · Employees: 9000+ · Revenue: ¥361.6B · Market cap: ¥130.2B